nodes	percent_of_prediction	percent_of_DWPC	metapath
Aztreonam—Nasal congestion—Temozolomide—skin cancer	0.00491	0.00491	CcSEcCtD
Aztreonam—Erythema multiforme—Imiquimod—skin cancer	0.00488	0.00488	CcSEcCtD
Aztreonam—Tinnitus—Imiquimod—skin cancer	0.00481	0.00481	CcSEcCtD
Aztreonam—Flushing—Imiquimod—skin cancer	0.00479	0.00479	CcSEcCtD
Aztreonam—Diarrhoea—Vismodegib—skin cancer	0.00476	0.00476	CcSEcCtD
Aztreonam—Thrombophlebitis—Fluorouracil—skin cancer	0.00476	0.00476	CcSEcCtD
Aztreonam—Dermatitis exfoliative—Temozolomide—skin cancer	0.00474	0.00474	CcSEcCtD
Aztreonam—Swelling—Fluorouracil—skin cancer	0.00467	0.00467	CcSEcCtD
Aztreonam—Purpura—Temozolomide—skin cancer	0.00464	0.00464	CcSEcCtD
Aztreonam—Chest discomfort—Docetaxel—skin cancer	0.00463	0.00463	CcSEcCtD
Aztreonam—Cough—Vemurafenib—skin cancer	0.0046	0.0046	CcSEcCtD
Aztreonam—Bronchospasm—Bleomycin—skin cancer	0.00451	0.00451	CcSEcCtD
Aztreonam—Erythema—Imiquimod—skin cancer	0.00449	0.00449	CcSEcCtD
Aztreonam—Myalgia—Vemurafenib—skin cancer	0.00448	0.00448	CcSEcCtD
Aztreonam—Diplopia—Temozolomide—skin cancer	0.00447	0.00447	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00445	0.00445	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00445	0.00445	CcSEcCtD
Aztreonam—Vomiting—Vismodegib—skin cancer	0.00442	0.00442	CcSEcCtD
Aztreonam—Rash—Vismodegib—skin cancer	0.00439	0.00439	CcSEcCtD
Aztreonam—Dermatitis—Vismodegib—skin cancer	0.00438	0.00438	CcSEcCtD
Aztreonam—Pancytopenia—Bleomycin—skin cancer	0.00435	0.00435	CcSEcCtD
Aztreonam—Anaphylactic shock—Vemurafenib—skin cancer	0.0043	0.0043	CcSEcCtD
Aztreonam—Ill-defined disorder—Imiquimod—skin cancer	0.00417	0.00417	CcSEcCtD
Aztreonam—Nausea—Vismodegib—skin cancer	0.00413	0.00413	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00412	0.00412	CcSEcCtD
Aztreonam—Angioedema—Imiquimod—skin cancer	0.0041	0.0041	CcSEcCtD
Aztreonam—Pancytopenia—Dactinomycin—skin cancer	0.00406	0.00406	CcSEcCtD
Aztreonam—Malaise—Imiquimod—skin cancer	0.00405	0.00405	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00403	0.00403	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00403	0.00403	CcSEcCtD
Aztreonam—Hypotension—Vemurafenib—skin cancer	0.00402	0.00402	CcSEcCtD
Aztreonam—Neutropenia—Dactinomycin—skin cancer	0.00399	0.00399	CcSEcCtD
Aztreonam—Stomatitis—Bleomycin—skin cancer	0.00398	0.00398	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00394	0.00394	CcSEcCtD
Aztreonam—Cough—Imiquimod—skin cancer	0.00392	0.00392	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00392	0.00392	CcSEcCtD
Aztreonam—Candida infection—Docetaxel—skin cancer	0.00391	0.00391	CcSEcCtD
Aztreonam—Convulsion—Imiquimod—skin cancer	0.00389	0.00389	CcSEcCtD
Aztreonam—Abdominal distension—Temozolomide—skin cancer	0.00389	0.00389	CcSEcCtD
Aztreonam—Chest pain—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Aztreonam—Myalgia—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Aztreonam—Discomfort—Imiquimod—skin cancer	0.00378	0.00378	CcSEcCtD
Aztreonam—Sweating increased—Temozolomide—skin cancer	0.00376	0.00376	CcSEcCtD
Aztreonam—Stomatitis—Dactinomycin—skin cancer	0.00371	0.00371	CcSEcCtD
Aztreonam—Haemoglobin—Bleomycin—skin cancer	0.00368	0.00368	CcSEcCtD
Aztreonam—Pancytopenia—Temozolomide—skin cancer	0.00367	0.00367	CcSEcCtD
Aztreonam—Haemorrhage—Bleomycin—skin cancer	0.00367	0.00367	CcSEcCtD
Aztreonam—Neutropenia—Temozolomide—skin cancer	0.00361	0.00361	CcSEcCtD
Aztreonam—Hyperhidrosis—Imiquimod—skin cancer	0.00354	0.00354	CcSEcCtD
Aztreonam—Eosinophilia—Fluorouracil—skin cancer	0.00352	0.00352	CcSEcCtD
Aztreonam—Phlebitis—Docetaxel—skin cancer	0.00345	0.00345	CcSEcCtD
Aztreonam—Thrombophlebitis—Docetaxel—skin cancer	0.00343	0.00343	CcSEcCtD
Aztreonam—Hepatitis—Dactinomycin—skin cancer	0.00342	0.00342	CcSEcCtD
Aztreonam—Flushing—Bleomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Aztreonam—Body temperature increased—Vemurafenib—skin cancer	0.0034	0.0034	CcSEcCtD
Aztreonam—Pancytopenia—Fluorouracil—skin cancer	0.00338	0.00338	CcSEcCtD
Aztreonam—Swelling—Docetaxel—skin cancer	0.00337	0.00337	CcSEcCtD
Aztreonam—Stomatitis—Temozolomide—skin cancer	0.00336	0.00336	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00334	0.00334	CcSEcCtD
Aztreonam—Insomnia—Imiquimod—skin cancer	0.00332	0.00332	CcSEcCtD
Aztreonam—Paraesthesia—Imiquimod—skin cancer	0.00329	0.00329	CcSEcCtD
Aztreonam—Dyspnoea—Imiquimod—skin cancer	0.00327	0.00327	CcSEcCtD
Aztreonam—Erythema multiforme—Dactinomycin—skin cancer	0.00323	0.00323	CcSEcCtD
Aztreonam—Erythema—Bleomycin—skin cancer	0.00319	0.00319	CcSEcCtD
Aztreonam—Flushing—Dactinomycin—skin cancer	0.00317	0.00317	CcSEcCtD
Aztreonam—Hypersensitivity—Vemurafenib—skin cancer	0.00317	0.00317	CcSEcCtD
Aztreonam—Pain—Imiquimod—skin cancer	0.00314	0.00314	CcSEcCtD
Aztreonam—Haemoglobin—Temozolomide—skin cancer	0.00311	0.00311	CcSEcCtD
Aztreonam—Stomatitis—Fluorouracil—skin cancer	0.00309	0.00309	CcSEcCtD
Aztreonam—Haemorrhage—Temozolomide—skin cancer	0.00309	0.00309	CcSEcCtD
Aztreonam—Hepatitis—Temozolomide—skin cancer	0.00309	0.00309	CcSEcCtD
Aztreonam—Asthenia—Vemurafenib—skin cancer	0.00308	0.00308	CcSEcCtD
Aztreonam—Pruritus—Vemurafenib—skin cancer	0.00304	0.00304	CcSEcCtD
Aztreonam—Feeling abnormal—Imiquimod—skin cancer	0.00302	0.00302	CcSEcCtD
Aztreonam—Gastrointestinal pain—Imiquimod—skin cancer	0.003	0.003	CcSEcCtD
Aztreonam—Erythema—Dactinomycin—skin cancer	0.00298	0.00298	CcSEcCtD
Aztreonam—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Aztreonam—Ill-defined disorder—Bleomycin—skin cancer	0.00296	0.00296	CcSEcCtD
Aztreonam—Anaemia—Bleomycin—skin cancer	0.00295	0.00295	CcSEcCtD
Aztreonam—Diarrhoea—Vemurafenib—skin cancer	0.00294	0.00294	CcSEcCtD
Aztreonam—Erythema multiforme—Temozolomide—skin cancer	0.00292	0.00292	CcSEcCtD
Aztreonam—Urticaria—Imiquimod—skin cancer	0.00291	0.00291	CcSEcCtD
Aztreonam—Abdominal pain—Imiquimod—skin cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Body temperature increased—Imiquimod—skin cancer	0.0029	0.0029	CcSEcCtD
Aztreonam—Tinnitus—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Malaise—Bleomycin—skin cancer	0.00288	0.00288	CcSEcCtD
Aztreonam—Flushing—Temozolomide—skin cancer	0.00287	0.00287	CcSEcCtD
Aztreonam—Haemoglobin—Fluorouracil—skin cancer	0.00286	0.00286	CcSEcCtD
Aztreonam—Haemorrhage—Fluorouracil—skin cancer	0.00285	0.00285	CcSEcCtD
Aztreonam—Dizziness—Vemurafenib—skin cancer	0.00284	0.00284	CcSEcCtD
Aztreonam—Cough—Bleomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Aztreonam—Ill-defined disorder—Dactinomycin—skin cancer	0.00276	0.00276	CcSEcCtD
Aztreonam—Anaemia—Dactinomycin—skin cancer	0.00275	0.00275	CcSEcCtD
Aztreonam—Vomiting—Vemurafenib—skin cancer	0.00273	0.00273	CcSEcCtD
Aztreonam—Myalgia—Bleomycin—skin cancer	0.00272	0.00272	CcSEcCtD
Aztreonam—Chest pain—Bleomycin—skin cancer	0.00272	0.00272	CcSEcCtD
Aztreonam—Rash—Vemurafenib—skin cancer	0.00271	0.00271	CcSEcCtD
Aztreonam—Dermatitis—Vemurafenib—skin cancer	0.00271	0.00271	CcSEcCtD
Aztreonam—Hypersensitivity—Imiquimod—skin cancer	0.0027	0.0027	CcSEcCtD
Aztreonam—Headache—Vemurafenib—skin cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Erythema—Temozolomide—skin cancer	0.00269	0.00269	CcSEcCtD
Aztreonam—Discomfort—Bleomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Malaise—Dactinomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00268	0.00268	CcSEcCtD
Aztreonam—Dysgeusia—Temozolomide—skin cancer	0.00264	0.00264	CcSEcCtD
Aztreonam—Asthenia—Imiquimod—skin cancer	0.00263	0.00263	CcSEcCtD
Aztreonam—Confusional state—Bleomycin—skin cancer	0.00263	0.00263	CcSEcCtD
Aztreonam—Alanine aminotransferase increased—Docetaxel—skin cancer	0.00262	0.00262	CcSEcCtD
Aztreonam—Anaphylactic shock—Bleomycin—skin cancer	0.0026	0.0026	CcSEcCtD
Aztreonam—Pruritus—Imiquimod—skin cancer	0.00259	0.00259	CcSEcCtD
Aztreonam—Nausea—Vemurafenib—skin cancer	0.00255	0.00255	CcSEcCtD
Aztreonam—Thrombocytopenia—Bleomycin—skin cancer	0.00255	0.00255	CcSEcCtD
Aztreonam—Myalgia—Dactinomycin—skin cancer	0.00253	0.00253	CcSEcCtD
Aztreonam—Bronchospasm—Docetaxel—skin cancer	0.00253	0.00253	CcSEcCtD
Aztreonam—Diarrhoea—Imiquimod—skin cancer	0.00251	0.00251	CcSEcCtD
Aztreonam—Discomfort—Dactinomycin—skin cancer	0.0025	0.0025	CcSEcCtD
Aztreonam—Ill-defined disorder—Temozolomide—skin cancer	0.0025	0.0025	CcSEcCtD
Aztreonam—Anaemia—Temozolomide—skin cancer	0.00249	0.00249	CcSEcCtD
Aztreonam—Erythema—Fluorouracil—skin cancer	0.00248	0.00248	CcSEcCtD
Aztreonam—Angioedema—Temozolomide—skin cancer	0.00246	0.00246	CcSEcCtD
Aztreonam—Pancytopenia—Docetaxel—skin cancer	0.00244	0.00244	CcSEcCtD
Aztreonam—Hypotension—Bleomycin—skin cancer	0.00243	0.00243	CcSEcCtD
Aztreonam—Malaise—Temozolomide—skin cancer	0.00243	0.00243	CcSEcCtD
Aztreonam—Dizziness—Imiquimod—skin cancer	0.00242	0.00242	CcSEcCtD
Aztreonam—Vertigo—Temozolomide—skin cancer	0.00242	0.00242	CcSEcCtD
Aztreonam—Neutropenia—Docetaxel—skin cancer	0.0024	0.0024	CcSEcCtD
Aztreonam—Thrombocytopenia—Dactinomycin—skin cancer	0.00238	0.00238	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00237	0.00237	CcSEcCtD
Aztreonam—Cough—Temozolomide—skin cancer	0.00235	0.00235	CcSEcCtD
Aztreonam—Paraesthesia—Bleomycin—skin cancer	0.00234	0.00234	CcSEcCtD
Aztreonam—Convulsion—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Aztreonam—Vomiting—Imiquimod—skin cancer	0.00233	0.00233	CcSEcCtD
Aztreonam—Dyspnoea—Bleomycin—skin cancer	0.00232	0.00232	CcSEcCtD
Aztreonam—Rash—Imiquimod—skin cancer	0.00231	0.00231	CcSEcCtD
Aztreonam—Dermatitis—Imiquimod—skin cancer	0.00231	0.00231	CcSEcCtD
Aztreonam—Headache—Imiquimod—skin cancer	0.0023	0.0023	CcSEcCtD
Aztreonam—Anaemia—Fluorouracil—skin cancer	0.00229	0.00229	CcSEcCtD
Aztreonam—Myalgia—Temozolomide—skin cancer	0.00229	0.00229	CcSEcCtD
Aztreonam—Discomfort—Temozolomide—skin cancer	0.00226	0.00226	CcSEcCtD
Aztreonam—Jaundice—Docetaxel—skin cancer	0.00223	0.00223	CcSEcCtD
Aztreonam—Stomatitis—Docetaxel—skin cancer	0.00223	0.00223	CcSEcCtD
Aztreonam—Pain—Bleomycin—skin cancer	0.00223	0.00223	CcSEcCtD
Aztreonam—Confusional state—Temozolomide—skin cancer	0.00222	0.00222	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00221	0.00221	CcSEcCtD
Aztreonam—Anaphylactic shock—Temozolomide—skin cancer	0.0022	0.0022	CcSEcCtD
Aztreonam—Nausea—Imiquimod—skin cancer	0.00218	0.00218	CcSEcCtD
Aztreonam—Thrombocytopenia—Temozolomide—skin cancer	0.00215	0.00215	CcSEcCtD
Aztreonam—Convulsion—Fluorouracil—skin cancer	0.00215	0.00215	CcSEcCtD
Aztreonam—Feeling abnormal—Bleomycin—skin cancer	0.00215	0.00215	CcSEcCtD
Aztreonam—Hyperhidrosis—Temozolomide—skin cancer	0.00212	0.00212	CcSEcCtD
Aztreonam—Chest pain—Fluorouracil—skin cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Myalgia—Fluorouracil—skin cancer	0.00211	0.00211	CcSEcCtD
Aztreonam—Discomfort—Fluorouracil—skin cancer	0.00209	0.00209	CcSEcCtD
Aztreonam—Pain—Dactinomycin—skin cancer	0.00208	0.00208	CcSEcCtD
Aztreonam—Urticaria—Bleomycin—skin cancer	0.00207	0.00207	CcSEcCtD
Aztreonam—Haemoglobin—Docetaxel—skin cancer	0.00207	0.00207	CcSEcCtD
Aztreonam—Body temperature increased—Bleomycin—skin cancer	0.00206	0.00206	CcSEcCtD
Aztreonam—Haemorrhage—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Aztreonam—Hepatitis—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Aztreonam—Confusional state—Fluorouracil—skin cancer	0.00204	0.00204	CcSEcCtD
Aztreonam—Anaphylactic shock—Fluorouracil—skin cancer	0.00202	0.00202	CcSEcCtD
Aztreonam—Feeling abnormal—Dactinomycin—skin cancer	0.002	0.002	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Temozolomide—skin cancer	0.002	0.002	CcSEcCtD
Aztreonam—Insomnia—Temozolomide—skin cancer	0.00199	0.00199	CcSEcCtD
Aztreonam—Gastrointestinal pain—Dactinomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Aztreonam—Thrombocytopenia—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Aztreonam—Paraesthesia—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Aztreonam—Dyspnoea—Temozolomide—skin cancer	0.00196	0.00196	CcSEcCtD
Aztreonam—Erythema multiforme—Docetaxel—skin cancer	0.00194	0.00194	CcSEcCtD
Aztreonam—Abdominal pain—Dactinomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Body temperature increased—Dactinomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Hypersensitivity—Bleomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Aztreonam—Flushing—Docetaxel—skin cancer	0.00191	0.00191	CcSEcCtD
Aztreonam—Hypotension—Fluorouracil—skin cancer	0.00189	0.00189	CcSEcCtD
Aztreonam—Pain—Temozolomide—skin cancer	0.00188	0.00188	CcSEcCtD
Aztreonam—Asthenia—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Pruritus—Bleomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Aztreonam—Insomnia—Fluorouracil—skin cancer	0.00183	0.00183	CcSEcCtD
Aztreonam—Paraesthesia—Fluorouracil—skin cancer	0.00182	0.00182	CcSEcCtD
Aztreonam—Feeling abnormal—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Aztreonam—Dyspnoea—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Gastrointestinal pain—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Aztreonam—Erythema—Docetaxel—skin cancer	0.00179	0.00179	CcSEcCtD
Aztreonam—Hypersensitivity—Dactinomycin—skin cancer	0.00179	0.00179	CcSEcCtD
Aztreonam—Dysgeusia—Docetaxel—skin cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Urticaria—Temozolomide—skin cancer	0.00175	0.00175	CcSEcCtD
Aztreonam—Asthenia—Dactinomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Abdominal pain—Temozolomide—skin cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Body temperature increased—Temozolomide—skin cancer	0.00174	0.00174	CcSEcCtD
Aztreonam—Pain—Fluorouracil—skin cancer	0.00173	0.00173	CcSEcCtD
Aztreonam—Feeling abnormal—Fluorouracil—skin cancer	0.00167	0.00167	CcSEcCtD
Aztreonam—Diarrhoea—Dactinomycin—skin cancer	0.00166	0.00166	CcSEcCtD
Aztreonam—Vomiting—Bleomycin—skin cancer	0.00166	0.00166	CcSEcCtD
Aztreonam—Anaemia—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Aztreonam—Rash—Bleomycin—skin cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Dermatitis—Bleomycin—skin cancer	0.00164	0.00164	CcSEcCtD
Aztreonam—Hypersensitivity—Temozolomide—skin cancer	0.00162	0.00162	CcSEcCtD
Aztreonam—Urticaria—Fluorouracil—skin cancer	0.00161	0.00161	CcSEcCtD
Aztreonam—Body temperature increased—Fluorouracil—skin cancer	0.0016	0.0016	CcSEcCtD
Aztreonam—Asthenia—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Aztreonam—Cough—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Aztreonam—Pruritus—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Convulsion—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Nausea—Bleomycin—skin cancer	0.00155	0.00155	CcSEcCtD
Aztreonam—Vomiting—Dactinomycin—skin cancer	0.00154	0.00154	CcSEcCtD
Aztreonam—Rash—Dactinomycin—skin cancer	0.00153	0.00153	CcSEcCtD
Aztreonam—Chest pain—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Myalgia—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Aztreonam—Diarrhoea—Temozolomide—skin cancer	0.0015	0.0015	CcSEcCtD
Aztreonam—Hypersensitivity—Fluorouracil—skin cancer	0.00149	0.00149	CcSEcCtD
Aztreonam—Confusional state—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Aztreonam—Anaphylactic shock—Docetaxel—skin cancer	0.00146	0.00146	CcSEcCtD
Aztreonam—Dizziness—Temozolomide—skin cancer	0.00145	0.00145	CcSEcCtD
Aztreonam—Nausea—Dactinomycin—skin cancer	0.00144	0.00144	CcSEcCtD
Aztreonam—Pruritus—Fluorouracil—skin cancer	0.00143	0.00143	CcSEcCtD
Aztreonam—Thrombocytopenia—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Aztreonam—Vomiting—Temozolomide—skin cancer	0.0014	0.0014	CcSEcCtD
Aztreonam—Rash—Temozolomide—skin cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Diarrhoea—Fluorouracil—skin cancer	0.00139	0.00139	CcSEcCtD
Aztreonam—Dermatitis—Temozolomide—skin cancer	0.00138	0.00138	CcSEcCtD
Aztreonam—Headache—Temozolomide—skin cancer	0.00138	0.00138	CcSEcCtD
Aztreonam—Hypotension—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Aztreonam—Dizziness—Fluorouracil—skin cancer	0.00134	0.00134	CcSEcCtD
Aztreonam—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Aztreonam—Insomnia—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Aztreonam—Paraesthesia—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Nausea—Temozolomide—skin cancer	0.00131	0.00131	CcSEcCtD
Aztreonam—Dyspnoea—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Aztreonam—Vomiting—Fluorouracil—skin cancer	0.00129	0.00129	CcSEcCtD
Aztreonam—Rash—Fluorouracil—skin cancer	0.00128	0.00128	CcSEcCtD
Aztreonam—Dermatitis—Fluorouracil—skin cancer	0.00128	0.00128	CcSEcCtD
Aztreonam—Headache—Fluorouracil—skin cancer	0.00127	0.00127	CcSEcCtD
Aztreonam—Pain—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Aztreonam—Feeling abnormal—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Nausea—Fluorouracil—skin cancer	0.0012	0.0012	CcSEcCtD
Aztreonam—Gastrointestinal pain—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Aztreonam—Abdominal pain—Docetaxel—skin cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Body temperature increased—Docetaxel—skin cancer	0.00116	0.00116	CcSEcCtD
Aztreonam—Hypersensitivity—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Aztreonam—Asthenia—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Aztreonam—Pruritus—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Aztreonam—Diarrhoea—Docetaxel—skin cancer	0.001	0.001	CcSEcCtD
Aztreonam—Dizziness—Docetaxel—skin cancer	0.000966	0.000966	CcSEcCtD
Aztreonam—Vomiting—Docetaxel—skin cancer	0.000929	0.000929	CcSEcCtD
Aztreonam—Rash—Docetaxel—skin cancer	0.000921	0.000921	CcSEcCtD
Aztreonam—Dermatitis—Docetaxel—skin cancer	0.00092	0.00092	CcSEcCtD
Aztreonam—Headache—Docetaxel—skin cancer	0.000915	0.000915	CcSEcCtD
Aztreonam—Nausea—Docetaxel—skin cancer	0.000868	0.000868	CcSEcCtD
